David Brailer - Walgreens Boots Independent Director

WBA Stock  USD 21.02  0.51  2.49%   

Director

Dr. David J. Brailer M.D., Ph.D. serves as Independent director of Walgreens boots alliance, inc. He is Chairman of Health Evolution Partners, a private equity firm focused on the healthcare industry, since 2006. He served as National Coordinator for Health Information Technology within the Department of Health and Human Services of the U.S. federal government from May 2004 to April 2006. He was a Senior Fellow at the Health Technology Center from 2002 to 2004. Previously, he served as Chairman and Chief Executive Officer and a director of CareScience, Inc., a provider of care management services and Internetbased healthcare solutions, from 1992 to 2002. Prior to that, he was Adjunct Assistant Professor of Health Care Systems at The Wharton School of Business at the University of Pennsylvania. He serves on the boards of directors of several private companies in the healthcare sector.
Age 58
Address 108 Wilmot Road, Deerfield, IL, United States, 60015
Phone847 315 3700
Webhttps://www.walgreensbootsalliance.com
Brailer served as National Coordinator for Health Information Technology within the Department of Health and Human Services of the U.S. federal government from May 2004 to April 2006. He was a Senior Fellow at the Health Technology Center from 2002 to 2004. Previously, he served as Chairman and Chief Executive Officer and a director of CareScience, Inc., a provider of care management services and Internetbased healthcare solutions, from 1992 to 2002. Prior to that, he was Adjunct Assistant Professor of Health Care Systems at The Wharton School of Business at the University of Pennsylvania.

Walgreens Boots Management Efficiency

The company has Return on Asset of 0.0132 % which means that on every $100 spent on assets, it made $0.0132 of profit. This is way below average. Walgreens Boots' management efficiency ratios could be used to measure how well Walgreens Boots manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to -0.1. The current year's Return On Assets is expected to grow to -0.03. At present, Walgreens Boots' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 98 B, whereas Total Current Assets are forecasted to decline to about 9.2 B.
The company has 33.53 B in debt with debt to equity (D/E) ratio of 1.2, which is OK given its current industry classification. Walgreens Boots Alliance has a current ratio of 0.74, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Walgreens Boots until it has trouble settling it off, either with new capital or with free cash flow. So, Walgreens Boots' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Walgreens Boots Alliance sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Walgreens to invest in growth at high rates of return. When we think about Walgreens Boots' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Susan KropfKroger Company
71
Michelle GloecklerBJs Wholesale Club
53
Mark SuttonKroger Company
59
Timothy McGuireDollar General
60
Clyde MooreKroger Company
66
Gregory BridgefordDollar Tree
62
Edward CerkovnikNatural Grocers By
63
Richard HalleNatural Grocers By
56
Thomas SaundersDollar Tree
80
Karen HoguetKroger Company
63
Robert SteeleBJs Wholesale Club
65
Ashok VemuriKroger Company
52
Michael CampbellNatural Grocers By
73
Ting TanWEBUY GLOBAL LTD
29
Anne GatesKroger Company
61
Bobby ShackoulsKroger Company
68
Christopher StadlerBJs Wholesale Club
53
Patricia FiliKrushelDollar General
67
Arnold BarronDollar Tree
69
Jeffrey NaylorDollar Tree
59
Ray ComptonDollar Tree
81
Walgreens Boots Alliance, Inc. operates as an integrated healthcare, pharmacy, and retailer in the United States , the United Kingdom, Germany, and internationally. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois. Walgreens Boots operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 200000 people. Walgreens Boots Alliance (WBA) is traded on NASDAQ Exchange in USA. It is located in 108 Wilmot Road, Deerfield, IL, United States, 60015 and employs 330,000 people. Walgreens Boots is listed under Consumer Staples Distribution & Retail category by Fama And French industry classification.

Management Performance

Walgreens Boots Alliance Leadership Team

Elected by the shareholders, the Walgreens Boots' board of directors comprises two types of representatives: Walgreens Boots inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Walgreens. The board's role is to monitor Walgreens Boots' management team and ensure that shareholders' interests are well served. Walgreens Boots' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Walgreens Boots' outside directors are responsible for providing unbiased perspectives on the board's policies.
Alexander Gourlay, Executive VP and President of Walgreens Co
James Skinner, Executive Chairman
David Brailer, Independent Director
Joseph Amsbary, Senior Secretary
Leonard Schaeffer, Independent Director
Nancy Schlichting, Independent Director
Dominic Murphy, Director
Jan Reed, Senior Vice President General Counsel, Corporatye Secretary
James Kehoe, Global CFO, Executive Vice President - Global
Anthony Roberts, Senior Vice President Global CIO
Holly May, Ex Officer
Beth Leonard, Senior Officer
Marco Pagni, Executive Vice President Global Chief Legal and Administrative Officer
Timothy Wentworth, CEO Director
John Lederer, Director
Ken Murphy, Executive Vice President of Walgreens Boots Alliance and Presidentident of Global Brands
Stefano Pessina, Executive Vice Chairman and CEO
Simon Roberts, Executive Vice President of Walgreens Boots Alliance and President of Boots
Matthew DAmbrosio, Senior Officer
Rick Gates, Senior Co
Neal Sample, Executive Officer
Gerald Gradwell, IR Contact Officer
Rosalind Brewer, CEO Director
Tracey Brown, President VP
Heather Dixon, Senior Vice President Chief Accounting Officer, Global Controller
Kimberly Scardino, Senior Vice President Chief Accounting Officer, Global Controller
Kathleen WilsonThompson, Executive Vice President Global Chief Human Resources Officer
Hsiao Wang, VP Officer
Jeffrey Berkowitz, Executive Vice President of Walgreens Boots Alliance and Presidentident of Pharma and Global Market Access
Ornella Barra, Executive Vice President of Walgreens Boots Alliance and Presidentident and Chief Executive of Global Wholesale and International Retail
Barry Rosenstein, Independent Director
Mia Scholz, Sr Operations
John Driscoll, Executive Healthcare
Jose Almeida, Director
Tiffany Kanaga, Vice Relations
Janice Babiak, Independent Director
Liyue Wu, Head Asia
Danielle Gray, Ex Officer
Manmohan Mahajan, Executive CFO
Todd Heckman, Interim VP
William Foote, Lead Independent Director
Ginger Graham, Independent Director
Aaron Radelet, Global VP
Natasha Polster, Compliance Quality
Aidan Clare, Senior Treasurer
George Fairweather, Global CFO and Executive VP
Elizabeth Burger, Executive Officer

Walgreens Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Walgreens Boots a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Walgreens Boots Alliance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Walgreens Boots' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Walgreens Boots Alliance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Walgreens Boots Alliance Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Walgreens Boots Alliance information on this page should be used as a complementary analysis to other Walgreens Boots' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Walgreens Stock analysis

When running Walgreens Boots' price analysis, check to measure Walgreens Boots' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Walgreens Boots is operating at the current time. Most of Walgreens Boots' value examination focuses on studying past and present price action to predict the probability of Walgreens Boots' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Walgreens Boots' price. Additionally, you may evaluate how the addition of Walgreens Boots to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Directory
Find actively traded commodities issued by global exchanges
Is Walgreens Boots' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Walgreens Boots. If investors know Walgreens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Walgreens Boots listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.59)
Dividend Share
1.92
Earnings Share
0.66
Revenue Per Share
165.003
Quarterly Revenue Growth
0.1
The market value of Walgreens Boots Alliance is measured differently than its book value, which is the value of Walgreens that is recorded on the company's balance sheet. Investors also form their own opinion of Walgreens Boots' value that differs from its market value or its book value, called intrinsic value, which is Walgreens Boots' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Walgreens Boots' market value can be influenced by many factors that don't directly affect Walgreens Boots' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Walgreens Boots' value and its price as these two are different measures arrived at by different means. Investors typically determine if Walgreens Boots is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Walgreens Boots' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.